Explore more publications!
Maryland Healthcare Reporter
Got News to Share?

Maryland Healthcare Reporter: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Maryland Healthcare Reporter.

September 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

October 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

Press releases published on September 2, 2025

Marlins for Mason event exceeds expectations, bringing in more than $680K for the Dravet Syndrome Foundation
September 2, 2025

Marlins for Mason event exceeds expectations, bringing in more than $680K for the Dravet Syndrome Foundation

Indeterminate EIN Presswire
Simmonds, Martin & Helmbrecht of Advantia Reopens Damascus Office
September 2, 2025

Simmonds, Martin & Helmbrecht of Advantia Reopens Damascus Office

Indeterminate EIN Presswire
Complimentary Webinar to Highlight Remote Scanning In-Suite Training Requirements and Responsibilities
September 2, 2025

Complimentary Webinar to Highlight Remote Scanning In-Suite Training Requirements and Responsibilities

Indeterminate EIN Presswire
Eisai Initiated Rolling Supplemental Biologics License Application to the U.S. FDA for LEQEMBI® IQLIK™ (lecanemab-irmb) as a Subcutaneous Starting Dose for the Treatment of Early Alzheimer’s Disease Under Fast Track Status
September 2, 2025

Eisai Initiated Rolling Supplemental Biologics License Application to the U.S. FDA for LEQEMBI® IQLIK™ (lecanemab-irmb) as a Subcutaneous Starting Dose for the Treatment of Early Alzheimer’s Disease Under Fast Track Status

Indeterminate GlobeNewswire
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
September 2, 2025

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Rapid Micro Biosystems to Present at the H.C. Wainwright 27th Annual Global Investment Conference
September 2, 2025

Rapid Micro Biosystems to Present at the H.C. Wainwright 27th Annual Global Investment Conference

Indeterminate GlobeNewswire
Flex Raises $15M to Unlock $150B in Untapped Pre-Tax Spending for Leading Health & Wellness Retailers
September 2, 2025

Flex Raises $15M to Unlock $150B in Untapped Pre-Tax Spending for Leading Health & Wellness Retailers

Indeterminate GlobeNewswire
Vaxart Announces Retirement of Chairman Michael J. Finney, Ph.D. from the Board of Directors
September 2, 2025

Vaxart Announces Retirement of Chairman Michael J. Finney, Ph.D. from the Board of Directors

Indeterminate GlobeNewswire
Korro to Participate in Upcoming Investor and Scientific Conferences
September 2, 2025

Korro to Participate in Upcoming Investor and Scientific Conferences

Indeterminate GlobeNewswire
Teva to Present at Morgan Stanley Global Healthcare Conference and Bank of America Global Healthcare Conference in September
September 2, 2025

Teva to Present at Morgan Stanley Global Healthcare Conference and Bank of America Global Healthcare Conference in September

Indeterminate GlobeNewswire
Nyxoah Announces Upcoming Investor Events
September 2, 2025

Nyxoah Announces Upcoming Investor Events

Indeterminate GlobeNewswire
Nyxoah Annonce ses Prochains Événements Destinés aux Investisseurs
September 2, 2025

Nyxoah Annonce ses Prochains Événements Destinés aux Investisseurs

Indeterminate GlobeNewswire
Entrada Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
September 2, 2025

Entrada Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Sanara MedTech Inc. Announces Chief Executive Officer Transition
September 2, 2025

Sanara MedTech Inc. Announces Chief Executive Officer Transition

Indeterminate GlobeNewswire
MacroGenics to Present at H.C. Wainwright 27th Annual Global Investment Conference
September 2, 2025

MacroGenics to Present at H.C. Wainwright 27th Annual Global Investment Conference

Indeterminate GlobeNewswire
Plus Therapeutics to Participate in Fireside Chat at the H.C. Wainwright 27th Annual Global Investment Conference
September 2, 2025

Plus Therapeutics to Participate in Fireside Chat at the H.C. Wainwright 27th Annual Global Investment Conference

Indeterminate GlobeNewswire
Nanobiotix to Participate in the H.C. Wainwright 27th Annual Global Investment Conference
September 2, 2025

Nanobiotix to Participate in the H.C. Wainwright 27th Annual Global Investment Conference

Indeterminate GlobeNewswire
Nanobiotix participera à la conférence investisseurs annuelle H.C. Wainwright global investment
September 2, 2025

Nanobiotix participera à la conférence investisseurs annuelle H.C. Wainwright global investment

Indeterminate GlobeNewswire
Certara to Participate in Upcoming Investor Conferences
September 2, 2025

Certara to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire
Lifecore Biomedical to Participate in Upcoming Investor Conferences
September 2, 2025

Lifecore Biomedical to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions